The journey of an Individual Case Safety Report (ICSR) begins with raw, unstructured information. A doctor's handwritten note, a patient's email, a PDF from a clinical study, or a call center transcript all contain crucial details about a potential adverse event. Manually sifting through these varied formats to find the four pillars of a valid case—an identifiable patient, a reporter, a suspect product, and an adverse event—is slow and prone to error. This is where AI-driven automation steps in, starting with the digital eyes of the system: Optical Character Recognition (OCR).

OCR technology scans images of documents, like PDFs or faxes, and converts them into machine-readable text. But raw text is still just a block of words. The next step is to understand what those words mean in context. This is the job of Natural Language Processing (NLP), a field of AI that gives computers the ability to read and interpret human language. An NLP model can parse a sentence like "The patient, a 45-year-old female, reported severe headaches after taking Drug X," and begin to classify each piece of information. When combined, OCR and NLP create a powerful duo that transforms a mountain of mixed-format documents into a stream of structured, analyzable data.

Once the source document is digitized, the system needs to find specific, critical pieces of information. This is accomplished using Named Entity Recognition (NER). NER models are trained to identify and categorize key entities within text. In pharmacovigilance, these entities aren't just names and places, but medically significant terms.

An NER model scans the narrative and flags:

• Patient Details: Age, sex, relevant medical history.
• Drug Names: Suspect drugs, concomitant medications.
• Adverse Events: Symptoms and diagnoses, such as "nausea" or "acute myocardial infarction."
• Timelines: Dates of administration, event onset, and recovery.

Crucially, the NER system doesn't just find these terms; it maps them to standardized terminologies like MedDRA. This automatically codes the event, transforming a descriptive phrase like "felt dizzy and sick to his stomach" into structured MedDRA terms for nausea and dizziness. This automated coding is a massive leap in efficiency and consistency compared to manual lookups.

Early automation in case processing relied heavily on Robotic Process Automation (RPA). Think of RPA as a set of digital hands that mimics repetitive, rule-based human actions. An RPA bot can be programmed to open an email, copy text from a specific field, and paste it into a database. It's fast and effective for highly structured, predictable tasks.

However, RPA struggles with variability. If a report format changes slightly or a narrative uses non-standard phrasing, the rigid rules of the bot can break. This is where modern Agentic AI systems show their strength. An AI agent, often powered by a Large Language Model (LLM), has contextual awareness. It doesn't just follow a script; it understands intent.

This contextual understanding allows an AI agent to perform much more complex tasks. For example, it can analyze a case narrative to infer seriousness even if the word "serious" isn't explicitly used. It can identify that a new report is a follow-up to an existing case, even if the patient ID has a typo, by matching other data points like date of birth and medical history. This intelligence is key to achieving true "touchless" processing, where cases flow from intake to validation with minimal human intervention. While an RPA bot might get stuck, an AI agent can flag the ambiguity and route the case to a human expert for review, complete with a summary of the issue. This creates a human-in-the-loop system that combines the speed of automation with the nuance of human expertise.

This advanced capability is particularly vital for duplicate detection and linking follow-up reports. An agentic system can perform a fuzzy search across the safety database, identifying likely duplicates that a simple, exact-match search would miss. By analyzing the narrative content, dates, and patient demographics, it can confidently link a new report to its initial case, ensuring a complete and accurate history for each adverse event.

By integrating these AI technologies, organizations are moving from a reactive, manual process to a proactive, automated workflow. This shift not only accelerates the processing of ICSRs but also improves data quality, ensuring that safety signals are detected faster and more reliably.